Sa. Kozeklangenecker et al., ANTICOAGULATION WITH PROSTAGLANDIN E-1 AND UNFRACTIONATED HEPARIN DURING CONTINUOUS VENOVENOUS HEMOFILTRATION, Critical care medicine, 26(7), 1998, pp. 1208-1212
Objective: To determine the effect of two doses of prostaglan din E-1
(PGE(1), alprostadil) combined with unfractionated heparin on the hemo
filter life-span and the coagulation profile during continuous venoven
ous hemofiltration. Design: Prospective, randomized, controlled trial.
Setting: Intensive care unit at a university-affiliated hospital. Pat
ients: Twenty-four critically ill, mechanically ventilated patients wi
th postoperative acute renal failure who require continuous venovenous
hemofiltration. Interventions: The patients were anticoagulated with
5 ng/kg/min PGE, and 6 IU/kg/hr heparin or 20 ng/kg/min PGE, and 6 IU/
kg/hr heparin, injected into the extracorporeal circuit before the hem
ofilter. Measurements and Main Results: The life-span of 43 hemofilter
s was evaluated, They were used until extracorporeal line pressure exc
eeded 250 mm Hg, ultrafiltration rate decreased to 16 ml/min, or gross
ly visible extracorporeal clotting occurred, Blood was sampled from th
e afferent (prefilter) and efferent (postfilter) lines of the extracor
poreal circuit, Platelet counts, in vitro platelet function, plasma co
ncentrations of platelet factor 4, prothrombin fragment F1+2, thrombin
-antithrombin complex, routine plasma coagulation tests, and hemodynam
ic profile were determined before and during hemofiltration, Hemofilte
r usage was significantly longer in patients anticoagulated with 20 ng
/kg/min PGE(1) (32 +/- 3 [SEM] hrs) than with 5 ng/kg/min PGE(1) (22 /- 3 hrs). In vitro bleeding parameters were significantly prolonged i
n postfilter blood in patients receiving 20 ng/kg/min PGE(1.) Prefilte
r, there was no antiplatelet activity in either group and platelet cou
nts remained stable, No intra- or intergroup differences in plasma coa
gulation profile or hemodynamic parameters were detected. Conclusion:
Extracorporeal administration of PGE(1), combined with low-dose hepari
nization, inhibits platelet reactivity and preserves hemofilter life d
ose-dependently.